Hamilton Thorne (CVE:HTL) Shares Up 4.3% – Here’s Why

Shares of Hamilton Thorne Ltd. (CVE:HTL) were up 4.3% during trading on Tuesday . The company traded as high as C$1.45 and last traded at C$1.45. Approximately 25,700 shares traded hands during mid-day trading, a decline of 27% from the average daily volume of 35,118 shares. The stock had previously closed at C$1.39.

Hamilton Thorne Stock Up 4.3%

The business’s 50-day moving average is C$1.45 and its two-hundred day moving average is C$1.45. The firm has a market capitalization of C$149.69 million, a price-to-earnings ratio of 58.94 and a beta of 0.54. The company has a debt-to-equity ratio of 16.60, a quick ratio of 2.25 and a current ratio of 3.20.

About Hamilton Thorne

Hamilton Thorne Ltd. develops, manufactures, and sells precision instruments, consumables, software, and services for the assisted reproductive technologies (ART), research, and cell biology markets. It offers precision laser systems, imaging systems, and other equipment and consumables for the ART and developmental biology research markets. The company also provides test laboratory and endotoxin testing services, as well as sperm assays, including Sperm Motility Index and Sperm Penetration; and fresh and cryopreserved mouse embryos supply, and technician training and proficiency testing services.